 This study evaluated the effect of 6 or 12 infusions of different doses of octagam intravenous immunoglobulin IVIG 10 on the reduction of amyloid beta peptide Aβ in cerebral spinal fluid CSF and on the increase of Aβ in blood plasma in patients with mild to moderate Alzheimers disease. 